A detailed history of Armor Investment Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Armor Investment Advisors, LLC holds 1,666 shares of LLY stock, worth $1.25 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares
1,666
Previous 1,666 -0.0%
Holding current value
$1.25 Million
Previous $1.51 Million 2.19%
% of portfolio
0.62%
Previous 0.71%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$724.87 - $909.04 $724 - $909
-1 Reduced 0.06%
1,666 $1.51 Million
Q1 2024

Apr 25, 2024

BUY
$592.2 - $792.28 $2,961 - $3,961
5 Added 0.3%
1,667 $1.3 Million
Q4 2023

Jan 19, 2024

SELL
$525.19 - $619.13 $309,336 - $364,667
-589 Reduced 26.17%
1,662 $968,000
Q3 2023

Oct 23, 2023

BUY
$434.7 - $599.3 $2,173 - $2,996
5 Added 0.22%
2,251 $1.21 Million
Q2 2023

Jul 19, 2023

BUY
$350.74 - $468.98 $2,104 - $2,813
6 Added 0.27%
2,246 $1.05 Million
Q1 2023

May 09, 2023

SELL
$310.63 - $364.82 $66,785 - $78,436
-215 Reduced 8.76%
2,240 $769,000
Q4 2022

Jan 30, 2023

BUY
$321.55 - $374.67 $24,437 - $28,474
76 Added 3.19%
2,455 $898,000
Q3 2022

Oct 31, 2022

BUY
$296.48 - $337.87 $12,452 - $14,190
42 Added 1.8%
2,379 $769,000
Q4 2020

Feb 11, 2021

BUY
$130.46 - $172.63 $304,885 - $403,436
2,337 New
2,337 $395,000
Q3 2020

Nov 09, 2020

SELL
$146.22 - $169.13 $341,716 - $395,256
-2,337 Closed
0 $0
Q4 2018

Feb 08, 2019

SELL
$105.9 - $118.64 $27,428 - $30,727
-259 Reduced 9.98%
2,337 $270,000
Q2 2018

Aug 13, 2018

SELL
$75.7 - $86.88 $22,710 - $26,064
-300 Reduced 10.36%
2,596 $222,000
Q1 2018

May 08, 2018

BUY
$74.21 - $87.6 $214,912 - $253,689
2,896 New
2,896 $224,000
Q4 2017

Feb 01, 2018

SELL
$81.94 - $87.89 $191,493 - $205,398
-2,337 Closed
0 $0
Q3 2017

Nov 02, 2017

BUY
$77.07 - $85.54 $180,112 - $199,906
2,337
2,337 $200,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Armor Investment Advisors, LLC Portfolio

Follow Armor Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armor Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armor Investment Advisors, LLC with notifications on news.